BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5304250)

  • 1. [Effects of the arginine-ornithine combination on the arterial ammonia levels in chronic liver diseases and hepatic coma].
    Miszputen SJ; Ganc AJ; Costa AA; Reibscheid S; Vilela MP
    AMB Rev Assoc Med Bras; 1968 Jul; 14(7):117-22. PubMed ID: 5304250
    [No Abstract]   [Full Text] [Related]  

  • 2. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Critical study of venous blood ammonia in hepatic coma. Diagnosis, surveillance and treatment].
    Dupuy R; Thiroloix J
    Rev Int Hepatol; 1967; 17(1):43-53. PubMed ID: 6060728
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hyperammoniemia].
    Nordmann R
    Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current views on the therapy of hepatic coma].
    Ziegler K
    Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of arginine in a recurrent hepatic coma complicating a feminizing tumor of the adrenal cortex with hepatic metastases].
    Imler M; Ruscher H; Peter B; Kurtz D; Stahl J
    Sem Hop; 1973 Nov; 49(48):3183-90. PubMed ID: 4364910
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hepatic coma: use of certain Krebs' urea cycle intermediates (L-arginine, DL-ornithine).
    WOLFE SJ; FAST BB; STORMONT JM; DAVIDSON CS
    J Lab Clin Med; 1958 May; 51(5):672-89. PubMed ID: 13539483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of severe hyperammonemia].
    Leonhardt H; Bungert HJ
    Med Klin; 1972 Aug; 67(32):1052-6. PubMed ID: 5070916
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of coma in liver cirrhosis].
    Manenti F; Ferrari A
    Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
    Rahimi RS; Rockey DC
    Clin Liver Dis; 2015 Aug; 19(3):539-49. PubMed ID: 26195207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
    Ameri AA
    MMW Fortschr Med; 2010 Jun; 152(22):42-3. PubMed ID: 20590033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels].
    Zhou ZW; Zhong XN; Zhou BY; Xiang JF; Wang RH; Yi J
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):385-8. PubMed ID: 24025143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.